Study Complete
Sponsor ID
20040213
A Randomized, Double-blind, Placebo-controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects with Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation
Study Details
Protocol Summary
Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available
Locations
No locations found.